| Abrocitinib | Atopic Dermatitis | Q4 2022 |
| Apixaban | Deep vein thrombosis | ✓ |
| Azithromycin | Bacterial infection | ✓ |
| Baloxavir Marboxil | Anti-flu virus | ✓ |
| Bictegravir Sodium | HIV-1 infection | TBD |
| Canagliflozin | Type 2 Diabetes | ✓ |
| Ciprofloxacin HCL | Bacterial infection | ✓ |
| Clarithromycin | Bacterial infection | ✓ |
| Clascoterone | Acne Vulgaris | TBD |
| Crisaborole | Atopic Dermatitis | Q2 2022 |
| Dabigatran Etexilate Mesylate | anticoagulant | ✓ |
| Elagolix Sodium | Pain caused by endometriosis | ✓ |
| Eltrombopag Olamine | ITP&Aplastic anemia Thrombocytopenia | Q2 2022 |
| Ezetimibe | Hyperlipidemia | ✓ |
| LCZ696(Sacubitril+Valsartan) | Heart failure | ✓ |
| Ledipasvir | Hepatitis C | ✓ |
| Lenalidomide | Multiple Myeloma | ✓ |
| Levetiracetam | Epilepsy | ✓ |
| Niraparib Tosylate | Ovarian/Fallopian tube/primary peritoneal cancer | TBD |
| Pomalidomide | Multiple Myeloma | ✓ |
| Pregabalin | Diabetic Peripheral Neuropathic pain | ✓ |
| Relugolix | Prostate cancer, uterus fibrosis | Q1 2023 |
| Ribociclib | HR-positive, HER2-negative advanced or metastatic breast cancer | TBD |
| Rimegepant (Sulfate) | Migraine | Q4 2022 |
| Rivaroxaban | Deep venous thrombosis (DVT) | ✓ |
| Rosuvastatin Calcium | Hypercholesterolemia | ✓ |
| Ruxolitinib Phosphate | Atopic Dermatitis, Myelofibrosis | TBD |
| Sitagliptin phosphate | Diabetes | ✓ |
| Solifenacin | Overactive bladder symptoms | Q2 2022 |
| Sugammadex sodium | Reversal of drug-induced neuromuscular block | ✓ |
| Ticagrelor | Anticoagulant | ✓ |
| Tofacitinib Citrate | Active psoriatic arthritis | ✓ |
| Ubrogepant | Migraine | TBD |
| Vildagliptin | Diabetes | TBD |
| Velpatasvir | chronic Hepatitis C | ✓ |
| Venetoclax | Chronic lymphocytic leukemia, Small lymphocytic leukemia | TBD |
| Vericiguat | Heart failure | Q2 2023 |